Eflornithine Treatment of Refractory Pneumocystis carinii Pneumonia in Patients with Acquired Immunodeficiency Syndrome
- 1 January 1992
- Vol. 101 (1) , 67-74
- https://doi.org/10.1378/chest.101.1.67
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Corticosteroids Prevent Early Deterioration in Patients with Moderately Severe Pneumocystis carinii Pneumonia and the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1990
- Are Corticosteroids Beneficial as Adjunctive Therapy for Pneumocystis Pneumonia in AIDS?Annals of Internal Medicine, 1990
- Pneumocystis carinii Pneumonia: DiagnosisThe Journal of Infectious Diseases, 1988
- Prognostic Factors and Life Expectancy of Patients with Acquired Immunodeficiency Syndrome andPneumocystis cariniiPneumoniaAmerican Review of Respiratory Disease, 1987
- Trimethoprim-Sulfamethoxazole or Pentamidine for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1986
- Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other ImmunodeficienciesAnnals of Internal Medicine, 1984
- Chemotherapeutic implications of polyamine biosynthesis inhibitionClinical Pharmacology & Therapeutics, 1984
- Polyamine metabolism and functionAmerican Journal of Physiology-Cell Physiology, 1982
- Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogsJournal of the American Chemical Society, 1978
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976